Subscribe for $2

Subscribe for 2 $

Financial Data API

Terminal Financial Data API

C4 Therapeutics Aktie News & Pressemeldungen

C4 Therapeutics Eulerpool News

8/8/2024, 7:37:44 PM

Rekordumsätze bei Monster Beverage im zweiten Quartal 2024 trotz Marktverlangsamung

1

1

C4 Therapeutics Stock News

C4 Therapeutics is being monitored by journalists and investors worldwide. We gather the latest C4 Therapeutics news here.

January 8 ·
Yahoo
C4 Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 30 ·
Yahoo
Why C4 Therapeutics (CCCC) Is One of the Best Biotech Penny Stocks to Invest in Now?
December 8 ·
Yahoo
C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader
November 20 ·
Yahoo
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
November 6 ·
SeekingAlpha
C4 Therapeutics: Holding Fast To A Generous Valuation Heading Into An Important ASH Readout
November 6 ·
Yahoo
C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
November 5 ·
Yahoo
C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual Meeting
November 1 ·
Yahoo
C4 Therapeutics Third Quarter 2024 Earnings: Beats Expectations
November 1 ·
TipRanks
Analysts’ Top Healthcare Picks: C4 Therapeutics (CCCC), Alnylam Pharma (ALNY)
October 31 ·
TipRanks
C4 Therapeutics Advances in Protein Degradation Therapy

1

2

1

2

C4 Therapeutics Stock Press Releases

C4 Therapeutics regularly publishes news on the company's website that are relevant for investors.

Access the world's leading financial data and tools

Subscribe for $2